The generic drug, once used to treat a myriad of other diseases, was unleashed against coronavirus in an attempt to wield against the virus ravaging the globe.
In an ever-changing world of new regulations, partnerships, and strategy, one healthcare leader believes the U.S. market will be forever marked by COVID-19.
Earlier this month, the U.S. Food and Drug Administration (FDA) unveiled their steps to focus on not only preventing COVID-19, but treating the disease as well.
The U.S. Food and Drug Administration clarified its rules around personal protective equipment (PPE) and its Emergency Use Authorizations regarding COVID-19.
As controversy heightens around potential treatments for COVID-19, government agencies and drug manufacturers are scrambling to find up-to-date information regarding authorized use.